Genomics in the era of COVID-19: ethical implications for clinical practice and public health

Gail Geller; Priya Duggal; Chloe L. Thio; Debra Mathews; Jeffrey P. Kahn; Lisa L. Maragakis; Brian T. Garibaldi

doi:10.1186/s13073-020-00792-9

Genomics in the era of COVID-19: ethical implications for clinical practice and public health

Gail Geller, Priya Duggal, Chloe L. Thio, Debra Mathews, Jeffrey P. Kahn, Lisa L. Maragakis, Brian T. Garibaldi

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Abstract

Genomic studies of patients with COVID-19, or exposed to it, are underway to delineate host factors associated with variability in susceptibility, infectivity, and disease severity. Here, we highlight the ethical implications—both potential benefits and harms—of genomics for clinical practice and public health in the era of COVID-19.

Original language	English (US)
Article number	95
Journal	Genome Medicine
Volume	12
Issue number	1
DOIs	https://doi.org/10.1186/s13073-020-00792-9
State	Published - Dec 2020

Keywords

COVID-19
Ethics
Host genomics

ASJC Scopus subject areas

Molecular Medicine
Molecular Biology
Genetics
Genetics(clinical)

Access to Document

10.1186/s13073-020-00792-9

Cite this

@article{f6bbd67d08704f7189b39ff958f04faf,

title = "Genomics in the era of COVID-19: ethical implications for clinical practice and public health",

abstract = "Genomic studies of patients with COVID-19, or exposed to it, are underway to delineate host factors associated with variability in susceptibility, infectivity, and disease severity. Here, we highlight the ethical implications—both potential benefits and harms—of genomics for clinical practice and public health in the era of COVID-19.",

keywords = "COVID-19, Ethics, Host genomics",

author = "Gail Geller and Priya Duggal and Thio, {Chloe L.} and Debra Mathews and Kahn, {Jeffrey P.} and Maragakis, {Lisa L.} and Garibaldi, {Brian T.}",

note = "Publisher Copyright: {\textcopyright} 2020, The Author(s).",

year = "2020",

month = dec,

doi = "10.1186/s13073-020-00792-9",

language = "English (US)",

volume = "12",

journal = "Genome Medicine",

issn = "1756-994X",

publisher = "BioMed Central",

number = "1",

}

TY - JOUR

T1 - Genomics in the era of COVID-19

T2 - ethical implications for clinical practice and public health

AU - Geller, Gail

AU - Duggal, Priya

AU - Thio, Chloe L.

AU - Mathews, Debra

AU - Kahn, Jeffrey P.

AU - Maragakis, Lisa L.

AU - Garibaldi, Brian T.

PY - 2020/12

Y1 - 2020/12

N2 - Genomic studies of patients with COVID-19, or exposed to it, are underway to delineate host factors associated with variability in susceptibility, infectivity, and disease severity. Here, we highlight the ethical implications—both potential benefits and harms—of genomics for clinical practice and public health in the era of COVID-19.

AB - Genomic studies of patients with COVID-19, or exposed to it, are underway to delineate host factors associated with variability in susceptibility, infectivity, and disease severity. Here, we highlight the ethical implications—both potential benefits and harms—of genomics for clinical practice and public health in the era of COVID-19.

KW - COVID-19

KW - Ethics

KW - Host genomics

UR - http://www.scopus.com/inward/record.url?scp=85095721702&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85095721702&partnerID=8YFLogxK

U2 - 10.1186/s13073-020-00792-9

DO - 10.1186/s13073-020-00792-9

M3 - Article

C2 - 33168072

AN - SCOPUS:85095721702

SN - 1756-994X

VL - 12

JO - Genome Medicine

JF - Genome Medicine

IS - 1

M1 - 95

ER -

Genomics in the era of COVID-19: ethical implications for clinical practice and public health

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this